calcium acetate

It is formulated by 12 pharmaceutical companies such as PADAGIS US, FRESENIUS MEDCL, CHARTWELL RX and others. It is marketed under 2 brand names, including CALCIUM ACETATE, PHOSLYRA. Available in 2 different strengths, such as 667MG, 667MG/5ML, and administered through 3 routes including TABLET;ORAL, SOLUTION;ORAL, CAPSULE;ORAL.

Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 12 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...

watch_later Watch: autorenew Loading watch analysis...

rocket_launch Opportunity: autorenew Loading opportunity analysis...

Country

flag

Legal Status

gavel

Expiry From

calendar_today

Expiry To

calendar_today

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength	Route of Administration	Companies	Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

	Patent Number	Publication Date	Legal Status	Patent Expiry Date
{"application_id":"76699","ingredient":"CALCIUM ACETATE","trade_name":"PHOSLYRA","family_id":"f61b312931844c64b99d","publication_number":"US8592480B2","cleaned_patent_number":"8592480","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-07-20","publication_date":"2013-11-26","legal_status":"Granted"}	US8592480B2	26 Nov, 2013	Granted	20 Jul, 2027
{"application_id":"76720","ingredient":"CALCIUM ACETATE","trade_name":"PHOSLYRA","family_id":"f61b312931844c64b99d","publication_number":"US9089528B2","cleaned_patent_number":"9089528","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-07-20","publication_date":"2015-07-28","legal_status":"Expired"}	US9089528B2	28 Jul, 2015	Expired	20 Jul, 2027
{"application_id":"76719","ingredient":"CALCIUM ACETATE","trade_name":"PHOSLYRA","family_id":"f61b312931844c64b99d","publication_number":"US8591938B2","cleaned_patent_number":"8591938","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-02-23","publication_date":"2013-11-26","legal_status":"Granted"}	US8591938B2 Formulation	26 Nov, 2013	Granted	23 Feb, 2030

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID	Title	Status	Phase	Conditions	Start Date	Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

Filter by Country

AMNEAL PHARMS Total Dosages: 1

CHARTWELL MOLECULAR Total Dosages: 1

CHARTWELL RX Total Dosages: 1

CYPRESS PHARM Total Dosages: 1 Manufacturing Locations: 1

HERITAGE PHARMS INC Total Dosages: 2

HIKMA Total Dosages: 2 Manufacturing Locations: 6

INVAGEN PHARMS Total Dosages: 1

LOTUS PHARM CO LTD Total Dosages: 1

LUPIN LTD Total Dosages: 1 Manufacturing Locations: 1

MPP PHARMA Total Dosages: 1

PADAGIS US Total Dosages: 1 Manufacturing Locations: 1

SQUARE PHARMS Total Dosages: 1

SUVEN PHARMS Total Dosages: 1

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.